Recombinant FGL1 antibody (AA 18-312)
Quick Overview for Recombinant FGL1 antibody (AA 18-312) (ABIN7453972)
Target
See all FGL1 AntibodiesAntibody Type
Reactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 18-312
-
Purpose
- Rabbit anti-Hepassocin/FGL1 Recombinant Monoclonal Antibody [BLR210K] - BSA-Free
-
Purification
- Purified
-
Immunogen
- residues 18-312 (full length)
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1000 μg/mL
-
Buffer
- Borate Buffered Saline (BBS) pH 8.2 with 0.09 % Sodium Azide, BSA-Free
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C
-
Storage Comment
- 2 - 8 °C
-
Expiry Date
- 12 months
-
-
- FGL1 (Fibrinogen-Like 1 (FGL1))
-
Alternative Name
- Hepassocin/FGL1
-
Background
- Hepassocin, also known as Fibrinogen-like 1 (FGL1), is a member of the fibrinogen family whose members share a fibrinogen domain at their C-termini. However, it lacks the platelet-binding site, cross-linking region and thrombin-sensitive site which are necessary for fibrin clot formation. Hepassocin/FGL1 is secreted by hepatocytes and may play a role in the development of hepatocellular carcinomas. Hepassocin/FGL1 is an immune suppressive molecule that inhibits antigen-specific T-cell activation by acting as a major ligand of LAG3 [taken from NCBI Entrez Gene (Gene ID: 2267)].
-
Gene ID
- 2267
-
UniProt
- Q08830
Target
-